Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion

Area of Science:

• Hepatology
• Virology
• Genomics

Background:

• Hepatitis B virus (HBV) integration into host DNA is an early event in infection, potentially driving hepatocellular carcinoma (HCC).
• The precise timing of pro-oncogenic changes and selective advantage during hepatocarcinogenesis remains unclear.
• Clonal expansion of hepatocytes with selective advantage occurs before cancer formation in chronic HBV infection, particularly during HBeAg-seroconversion.

Purpose of the Study:

• To investigate whether HBV DNA integration events confer a selective advantage during hepatocarcinogenesis.
• To analyze genomic and functional patterns adjacent to HBV DNA integration sites.
• To determine if HBV integration sites are enriched in specific genomic features during the clonal expansion phase.

Main Methods:

• Analysis of 717 unique HBV DNA integration events from patients (n=41) with and without HBeAg-seroconversion and an in vitro model.
• Examination of host genomic sequences adjacent to HBV integration sites.
• In silico modeling to control for detection biases.

Main Results:

• HBV DNA integration sites were distributed broadly across the host genome.
• No significant enrichment of specific structural or functional genomic features was observed near integration sites during HBeAg-seroconversion.
• No significant selection for or against specific cellular sites of HBV DNA integration was detected during clonal expansion.

Conclusions:

• HBV DNA integration events do not appear to be actively selected for during the clonal expansion phase of chronic HBV infection.
• These integration events are likely passenger events rather than drivers of liver cancer.
• The findings challenge the previous hypothesis that HBV integration actively drives hepatocarcinogenesis through insertional mutagenesis or gene activation.